Ray Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Ray Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD) (NCT07502664) | Ray Therapeutics, Inc. | 2026-02-19 |
| Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease (NCT07439887) | Ray Therapeutics, Inc. | 2026-01-28 |
| Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) (NCT06460844) | Ray Therapeutics, Inc. | 2024-08-27 |
| Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration (NCT06375239) | Ray Therapeutics, Inc. | 2024-04-05 |
Track Ray Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.